Jowon Laura Kim

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma 65 (3) (2023)
Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma (2023)
Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma 65 (3) (2023)